Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

70.52
+0.65940.94%
Post-market: 70.520.00000.00%16:10 EDT
Volume:324
Turnover:22.85K
Market Cap:705.23K
PE:- -
High:70.60
Open:70.59
Low:70.43
Close:69.86
52wk High:85.03
52wk Low:55.03
Shares:10.00K
Float Shares:10.00K
Volume Ratio:0.74
T/O Rate:3.24%
Dividend:2.07
Dividend Rate:2.94%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Jun 10

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

TIPRANKS
·
Jun 10

Top Midday Stories: GSK to Acquire Nuvalent for $10.6 Billion in Cash; Apple Introduces Siri AI, But EU Launch to be Delayed

MT Newswires Live
·
Jun 09

Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal -- Barrons.com

Dow Jones
·
Jun 09

GSK's Nuvalent Deal Makes Strategic Sense -- Market Talk

Dow Jones
·
Jun 09

Video: Nuvalent jumps after GSK’s $10.6B takeover deal

TIPRANKS
·
Jun 09

Nuvalent Shares Soar Following GSK's Acquisition Announcement

Deep News
·
Jun 09

GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs

Deep News
·
Jun 09

Nuvalent to Be Acquired by GSK in Cash Deal

TIPRANKS
·
Jun 09

How a former lawyer is beating the stock market with these 11 picks

Dow Jones
·
Jun 09

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 09

Nuvalent Shares Leap Premarket on Takeover by GSK

Dow Jones
·
Jun 09

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 09

GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent

Deep News
·
Jun 09

GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk

Dow Jones
·
Jun 09

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

Dow Jones
·
Jun 09

GSK paying 40% premium to boost the cancer business it previously unwound

Dow Jones
·
Jun 09

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Dow Jones
·
Jun 09

Dow Jones Top Company Headlines at 3 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...

Dow Jones
·
Jun 09

GSK to buy Nuvalent in $10.6bn deal to fast-track lung cancer push

TIPRANKS
·
Jun 09